AERIE PHARMACEUTICALS (AERI)

Chart for AERI

Over the next 13 weeks, AERIE PHARMACEUTICALS has on average historically risen by 25.2% based on the past 3 years of stock performance.

AERIE PHARMACEUTICALS has risen higherby an average 25.2%in 1 of those 3 years over the subsequent 13 week period,corresponding to a historical probability of 33%

The holding period that leads to the greatest annualized return for AERIE PHARMACEUTICALS, based on historical prices, is 11 weeks. Should AERIE PHARMACEUTICALS stock move in the future similarly to its average historical movement over this duration, an annualized return of 114% could result.

Clovis Oncology, Inc. (CLVS)

Chart for CLVS

Over the next 13 weeks, Clovis Oncology, Inc. has on average historically fallen by 24.4% based on the past 5 years of stock performance.

Clovis Oncology, Inc. has fallen lowerby an average 24.4%in 3 of those 5 years over the subsequent 13 week period,corresponding to a historical probability of 60%

The holding period that leads to the greatest annualized return for Clovis Oncology, Inc., based on historical prices, is 44 weeks. Should Clovis Oncology, Inc. stock move in the future similarly to its average historical movement over this duration, an annualized return of 62% could result.

DTS Inc. (DTSI)

Chart for DTSI

Over the next 13 weeks, DTS Inc. has on average historically fallen by 0.8% based on the past 13 years of stock performance.

DTS Inc. has fallen lowerby an average 0.8%in 7 of those 13 years over the subsequent 13 week period,corresponding to a historical probability of 53%

The holding period that leads to the greatest annualized return for DTS Inc., based on historical prices, is 37 weeks. Should DTS Inc. stock move in the future similarly to its average historical movement over this duration, an annualized return of 3% could result.

Intercept Pharmaceuticals, Inc. (ICPT)

Chart for ICPT

Over the next 13 weeks, Intercept Pharmaceuticals, Inc. has on average historically fallen by 20.2% based on the past 4 years of stock performance.

Intercept Pharmaceuticals, Inc. has fallen lowerby an average 20.2%in 3 of those 4 years over the subsequent 13 week period,corresponding to a historical probability of 75%

The holding period that leads to the greatest annualized return for Intercept Pharmaceuticals, Inc., based on historical prices, is 17 weeks. Should Intercept Pharmaceuticals, Inc. stock move in the future similarly to its average historical movement over this duration, an annualized return of 528% could result.

Puma Biotechnology, Inc. (PBYI)

Chart for PBYI

Over the next 13 weeks, Puma Biotechnology, Inc. has on average historically risen by 14.6% based on the past 4 years of stock performance.

Puma Biotechnology, Inc. has risen higherby an average 14.6%in 2 of those 4 years over the subsequent 13 week period,corresponding to a historical probability of 50%

The holding period that leads to the greatest annualized return for Puma Biotechnology, Inc., based on historical prices, is 52 weeks. Should Puma Biotechnology, Inc. stock move in the future similarly to its average historical movement over this duration, an annualized return of 137% could result.

Sarepta Therapeutics, Inc. (SRPT)

Chart for SRPT

Over the next 13 weeks, Sarepta Therapeutics, Inc. has on average historically fallen by 4.9% based on the past 19 years of stock performance.

Sarepta Therapeutics, Inc. has fallen lowerby an average 4.9%in 11 of those 19 years over the subsequent 13 week period,corresponding to a historical probability of 57%

The holding period that leads to the greatest annualized return for Sarepta Therapeutics, Inc., based on historical prices, is 2 weeks. Should Sarepta Therapeutics, Inc. stock move in the future similarly to its average historical movement over this duration, an annualized return of 205% could result.

Tobira Therapeutics Inc (TBRA)

Chart for TBRA

Over the next 13 weeks, Tobira Therapeutics Inc has on average historically fallen by 27.6% based on the past 3 years of stock performance.

Tobira Therapeutics Inc has fallen lowerby an average 27.6%in 3 of those 3 years over the subsequent 13 week period,corresponding to a historical probability of 100%

The holding period that leads to the greatest annualized return for Tobira Therapeutics Inc, based on historical prices, is 39 weeks. Should Tobira Therapeutics Inc stock move in the future similarly to its average historical movement over this duration, an annualized return of 53% could result.